STRIDE INC (LRN) Stock Analyst Ratings
USA - NYSE:LRN - US86333M1080 - Common Stock
62.88 USD
-1.22 (-1.9%)
ChartMill assigns a Buy % Consensus number of 82% to LRN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 171.83. This target is 173.26% above the current price.
LRN was analyzed by 11 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about LRN.
In the previous month the buy percentage consensus was at a similar level.
LRN was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-29 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-10-29 | BMO Capital | Downgrade | Outperform -> Market Perform |
| 2025-10-29 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-10-24 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-09-23 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-08-29 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-08-06 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-24 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-04-30 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-04-28 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-04-17 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-04-01 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-03-14 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-03-11 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-01-30 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-01-29 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-01-29 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-01-27 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-01-17 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-12-12 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-10-29 | Citigroup | Maintains | Neutral -> Neutral |
| 2024-10-24 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-10-23 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-10-23 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-10-11 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-09-20 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-08-20 | Citigroup | Downgrade | Buy -> Neutral |
| 2024-08-08 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-08-08 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-08-08 | Canaccord Genuity | Initiate | Buy |
STRIDE INC / LRN FAQ
What is the average price target for STRIDE INC (LRN) stock?
11 analysts have analysed LRN and the average price target is 171.83 USD. This implies a price increase of 173.26% is expected in the next year compared to the current price of 62.88.
Can you provide the consensus rating for STRIDE INC stock?
The consensus rating for STRIDE INC (LRN) is 81.8182 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover STRIDE INC (LRN) stock?
The number of analysts covering STRIDE INC (LRN) is 11.